| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/08/2023 | Annexon, Inc. | ANNX | Grant | Stock Option (Right to Buy) | 24k | $2.88 | $69.1k | | 06/08/2023 |
| 01/16/2023 | Protagonist Therapeutics, Inc | PTGX | Grant | Stock Option (right to buy) | 30k | $12.17 | $365.1k | | 01/16/2023 |
| 01/10/2023 | ARROWHEAD PHARMACEUTICALS, INC. | ARWR | Grant | Common Stock | 4.6k | $33.03 | $151.7k | | 01/09/2023 |
| 01/10/2023 | ARROWHEAD PHARMACEUTICALS, INC. | ARWR | Grant | Common Stock | 7.9k | $0.00 | $0 | | 01/09/2023 |
| 01/09/2023 | ARROWHEAD PHARMACEUTICALS, INC. | ARWR | Sale | Common Stock | 3.2k | $30.00 | $96k | | 01/09/2023 |
| 06/09/2022 | Annexon, Inc. | ANNX | Grant | Stock Option (Right to Buy) | 24k | $3.84 | $92.2k | | 06/09/2022 |
| 05/26/2022 | Protagonist Therapeutics, Inc | PTGX | Grant | Stock Option (right to buy) | 20k | $8.31 | $166.2k | | 05/26/2022 |
| 05/03/2022 | Protagonist Therapeutics, Inc | PTGX | Exercise | Stock Option (right to buy) | 12k | $8.59 | $103.1k | | 05/03/2022 |
| 01/07/2022 | ARROWHEAD PHARMACEUTICALS, INC. | ARWR | Grant | Common Stock | 6.4k | $0.00 | $0 | | 01/07/2022 |
| 01/03/2022 | ARROWHEAD PHARMACEUTICALS, INC. | ARWR | Sale | Common Stock | 2.1k | $64.23 | $134.9k | | 01/03/2022 |
| 01/03/2022 | ARROWHEAD PHARMACEUTICALS, INC. | ARWR | Sale | Common Stock | 2.1k | $65.01 | $138.3k | | 01/03/2022 |
| 01/03/2022 | ARROWHEAD PHARMACEUTICALS, INC. | ARWR | Sale | Common Stock | 272 | $66.25 | $18k | | 01/03/2022 |
| 08/12/2021 | Annexon, Inc. | ANNX | Grant | Stock Option (Right to Buy) | 20k | $19.73 | $394.6k | | 08/12/2021 |
| 05/27/2021 | Protagonist Therapeutics, Inc | PTGX | Grant | Stock Option (right to buy) | 18k | $35.23 | $634.1k | | 05/27/2021 |
| 01/04/2021 | ARROWHEAD PHARMACEUTICALS, INC. | ARWR | Sale | Common Stock | 3.8k | $76.08 | $285.3k | | 01/01/2021 |
| 01/01/2021 | ARROWHEAD PHARMACEUTICALS, INC. | ARWR | Grant | Common Stock | 9k | $0.00 | $0 | | 01/01/2021 |
| 12/10/2020 | ARROWHEAD PHARMACEUTICALS, INC. | ARWR | Sale | Common Stock | 1.8k | $73.10 | $131.6k | | 12/10/2020 |
| 12/10/2020 | ARROWHEAD PHARMACEUTICALS, INC. | ARWR | Sale | Common Stock | 1.2k | $68.50 | $82.2k | | 12/10/2020 |
| 05/28/2020 | Protagonist Therapeutics, Inc | PTGX | Grant | Stock Option (right to buy) | 15k | $16.54 | $248.1k | | 05/28/2020 |
| 05/11/2020 | ARROWHEAD PHARMACEUTICALS, INC. | ARWR | Sale | Common Stock | 26k | $36.54 | $950k | | 05/11/2020 |
| 01/01/2020 | ARROWHEAD PHARMACEUTICALS, INC. | ARWR | Grant | Common Stock | 7.5k | $0.00 | $0 | | 01/01/2020 |
| 06/07/2019 | Protagonist Therapeutics, Inc | PTGX | Grant | Stock Option (right to buy) | 12k | $11.80 | $141.6k | | 06/07/2019 |
| 01/11/2019 | ARROWHEAD PHARMACEUTICALS, INC. | ARWR | Sale | Common Stock | 8.5k | $14.77 | $125.5k | | 01/11/2019 |
| 01/01/2019 | ARROWHEAD PHARMACEUTICALS, INC. | ARWR | Grant | Common Stock | 30k | $0.00 | $0 | | 01/01/2019 |
| 05/29/2018 | Protagonist Therapeutics, Inc | PTGX | Grant | Stock Option (right to buy) | 12k | $6.98 | $83.8k | | 05/29/2018 |
| 01/01/2018 | ARROWHEAD PHARMACEUTICALS, INC. | ARWR | Grant | Common Stock | 25k | $0.00 | $0 | | 01/01/2018 |
| 07/23/2013 | OncoMed Pharmaceuticals Inc | OMED | Conversion | | 5.2k | $0.00 | $0 | See Footnote | 07/23/2013 |
| 07/23/2013 | OncoMed Pharmaceuticals Inc | OMED | Conversion | Common Stock | 5.2k | $0.00 | $0 | See Footnote | 07/23/2013 |